Mycobacterium ulcerans infection (Buruli or Bairnsdale ulcer): challenges in developing management strategies.
Asiedu
Kingsley
K
Wansbrough-Jones
Mark
M
D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D001315:Australia; D003131:Combined Modality Therapy; D004781:Environmental Exposure; D006801:Humans; D009165:Mycobacterium Infections, Nontuberculous / Q000175:diagnosis / Q000628:therapy*; D019911:Mycobacterium ulcerans / Q000235:genetics; D017410:Practice Guidelines as Topic; D017192:Skin Diseases, Bacterial / Q000175:diagnosis / Q000628:therapy; D012883:Skin Ulcer / Q000175:diagnosis / Q000628:therapy*
D000900:Anti-Bacterial Agents